# FDAcategoryD - Schema.org Enumeration Member

> Source: https://schema.org/FDAcategoryD
> Extracted: 2026-02-16T18:44:31.273Z

---

**Note**: You are viewing the development version of [Schema.org](https://schema.org/). See [how we work](https://schema.org/docs/howwework.html) for more details.

A Schema.org Enumeration Member

  [Thing](https://schema.org/Thing "Thing") \> [Intangible](https://schema.org/Intangible "Intangible") \> [Enumeration](https://schema.org/Enumeration "Enumeration") \> [MedicalEnumeration](https://schema.org/MedicalEnumeration "MedicalEnumeration") \> [DrugPregnancyCategory](https://schema.org/DrugPregnancyCategory "DrugPregnancyCategory") ::   [FDAcategoryD](https://schema.org/FDAcategoryD "FDAcategoryD")  

**\[more...\]**

-   Canonical URL: https://schema.org/FDAcategoryD
-   [Check for open issues.](https://github.com/schemaorg/schemaorg/issues?q=is%3Aissue+is%3Aopen+FDAcategoryD)

A designation by the US FDA signifying that there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

A member value for enumeration type: [DrugPregnancyCategory](https://schema.org/DrugPregnancyCategory "DrugPregnancyCategory")